CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- 4 Planned sale Chief Financial Officer sold 58,629 shares at an average $141.78 ($8,312,294)
- 4 Planned sale President and CEO sold 125,000 shares at an average $145.92 ($18,240,568)
- 4 Gift President and CEO gave 510 shares (gift)
- 4 Planned sale President and CEO sold 100,000 shares at an average $148.91 ($14,890,799)
- 4 Planned sale Director sold 9,000 shares at $117.94 ($1,061,460)
- 4 Planned sale Director sold 9,000 shares at $107.68 ($969,120)
- 4 Planned sale Director sold 9,000 shares at $99.64 ($896,760)
- 4/A Planned sale President and CEO sold 75,000 shares at $100.12 ($7,509,000)
- 4 Open-market sale President and CEO sold 75,000 shares at $100.12 ($7,509,000)
- 4 Open-market sale Director sold 59,130 shares at an average $100.10 ($5,918,880)
- 4 Gift President and CEO gave 1,460 shares (gift)
- 4 Open-market sale Chief Financial Officer sold 1,750 shares at $105.47 ($184,573)
- 4 Open-market sale Chief Medical Officer sold 15,000 shares at $104.79 ($1,571,850)
- 4 Open-market sale Director sold 24,000 shares at $105.00 ($2,520,000)
- 4 Open-market sale Chief Financial Officer sold 24,765 shares at $104.24 ($2,581,504)
- 4 Open-market sale President and CEO sold 54,700 shares at $101.00 ($5,524,700)
- 4 Open-market sale Director sold 18,000 shares at $82.42 ($1,483,560)
- 4 Open-market sale Director sold 20,000 shares at $83.68 ($1,673,600)
- 4 Open-market sale President and CEO sold 48,273 shares at an average $84.18 ($4,063,743)
- 4 Open-market sale Chief Financial Officer sold 46,203 shares at an average $83.13 ($3,841,037)
Page 1 of 15 · 291 filings